Skip to content

Muraleedharan Rejects Resignation Calls Amid Kerala Health Row

By News Analysis India · · 2 min read

Thiruvananthapuram, October 23: Amid a growing political storm over the health sector in Kerala, Health Minister K. Muraleedharan has firmly ruled out resigning. He hit back on Friday at criticism from three former women health ministers of the CPI(M) and raised questions about their own records in office.

The Congress leader took aim at the previous Left Democratic Front (LDF) government, stating that the period when surgical scissors were allegedly left inside patients after surgery was over.

In pointed remarks about the three former ministers, Muraleedharan said they had been ignored by their own party and were now uniting against him. “The Congress party has made me a minister,” he said, making it clear that he would not give up his post.

The remarks followed a joint statement issued a day earlier by P.K. Sreemathy, K.K. Shailaja and Veena George, all senior CPI(M) leaders and former health ministers. They had criticised the present government's handling of the health sector.

Muraleedharan claimed that children died from infections during one former minister's tenure, and that people lost their lives during the Nipah virus outbreak under another. He further accused the third former minister of making a false claim that she had been assaulted by him.

At the centre of the clash is the issue of medicines for children with spinal muscular atrophy (SMA). The former ministers had questioned the distribution of drugs written only for clinical trials and raised concerns over patient safety.

Sreemathy accused the government of an irresponsible policy that was making it hard for patients to get life-saving medicines. She said the LDF government had supplied medicines free of cost and that there were no shortage complaints in its decade in power.

She also alleged that the established procurement system of the Kerala Medical Services Corporation had been bypassed, which in turn had created corruption and distribution problems.

In response, Muraleedharan said the government would keep using India-made medicines instead of buying imported drugs for SMA patients. He blamed some TV channels for escalating the row and suggested that foreign drug companies might be behind some of the reports.

Support for the health department's move came from renowned neurosurgeon B. Iqbal, former Vice-Chancellor of the University of Kerala. He called the use of Risdiplam, a low-cost generic drug manufactured by Natco, a significant step towards making treatment more affordable.

The controversy over drug procurement, patient safety and the record of the previous LDF government has now grown into a major political contest. Although Muraleedharan holds the health portfolio rather than the chief minister's post, he has indicated he will not back away from the issue.